Clinical evidence of the antiarrhythmic effect of a magistral suspension of propafenone: a case report

Propafenone is an antiarrhythmic that has been used for the treatment of tachiarrytmias in both adults and children. The aim of this study was to analyze the pharmacologic effect of a magistral suspension of propafenone, due to lack of an adequate commercial formulation for use in children. In this...

Full description

Saved in:
Bibliographic Details
Published in:Archivos de cardiología de México 2009-04, Vol.79 (2), p.132-134
Main Authors: Barranco-Garduño, Lina, Flores-Pérez, Janett, Juárez-Olguín, Hugo, Bobadilla-Chávez, Jesús, Osnaya, Héctor, Flores-Pérez, Carmen
Format: Article
Language:English
Subjects:
Anti-Arrhythmia Agents - therapeutic use
Arrhythmias, Cardiac - drug therapy
Child, Preschool
Humans
Male
Propafenone - therapeutic use
Suspensions
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Propafenone is an antiarrhythmic that has been used for the treatment of tachiarrytmias in both adults and children. The aim of this study was to analyze the pharmacologic effect of a magistral suspension of propafenone, due to lack of an adequate commercial formulation for use in children. In this study we present, a case of a 2-year-old boy that was diagnosed with Wolff-Parkinson White syndrome and treated with a magistral suspension of propafenone. He has now been one year with no symptoms, no tachycardia and no cyanosis. The clinical status of the patient under treatment with propafenone was improved through constant medical care in the Cardiological Health Care Unit. The use of a magistral formulation of propafenone developed in our laboratory offers a temporal solution due to lack of medicines for children.
ISSN:1405-9940